Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review

Endothelial injury and microvascular/macrovascular thrombosis are common pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal thromboprophylactic regimens remain unknown across the spectrum of illness severity of COVID-19. A variety of antithrombotic agents, doses...

Descripción completa

Detalles Bibliográficos
Autores principales: Talasaz, Azita H., Sadeghipour, Parham, Kakavand, Hessam, Aghakouchakzadeh, Maryam, Kordzadeh-Kermani, Elaheh, Van Tassell, Benjamin W., Gheymati, Azin, Ariannejad, Hamid, Hosseini, Seyed Hossein, Jamalkhani, Sepehr, Sholzberg, Michelle, Monreal, Manuel, Jimenez, David, Piazza, Gregory, Parikh, Sahil A., Kirtane, Ajay J., Eikelboom, John W., Connors, Jean M., Hunt, Beverley J., Konstantinides, Stavros V., Cushman, Mary, Weitz, Jeffrey I., Stone, Gregg W., Krumholz, Harlan M., Lip, Gregory Y.H., Goldhaber, Samuel Z., Bikdeli, Behnood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American College of Cardiology Foundation. Published by Elsevier. 2021
Materias:
The Present and Future
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963001/
https://www.ncbi.nlm.nih.gov/pubmed/33741176
http://dx.doi.org/10.1016/j.jacc.2021.02.035

Ejemplares similares

Ejemplares similares